Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response.
about
Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyGetting TRAIL back on track for cancer therapyRegulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.Genetically engineered mouse models in oncology research and cancer medicineStructural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy.The structural network of Interleukin-10 and its implications in inflammation and cancerVaccines for cancer prevention: a practical and feasible approach to the cancer epidemic.Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapiesCombination immunotherapy: a road map.Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents.Leveraging premalignant biology for immune-based cancer prevention.Preclinical screening methods in cancer.Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology.Adapting Cancer Immunotherapy Models for the Real World.Cornerstones of CRISPR-Cas in drug discovery and therapy.Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy.Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node.
P2860
Q26779184-79B1856B-B748-461A-9AA1-AE10325844E4Q27027460-D7507D56-E853-44F3-A5D6-2AE895F31ACBQ27310763-C60E4DEB-49A9-42B0-BACD-61856C2FB1D9Q28079323-2E745590-E046-475C-9CC7-CF12CEBCA81FQ33820227-D0C4DECD-3DAE-492E-8AFD-0827583B0FB2Q33851564-08529A1D-E296-4D31-8539-AA675FDBE7B5Q34180316-27954419-52D7-4084-A950-5551EF4A5CE5Q34511672-32C2DF03-A88C-4157-9554-3C919EC093FBQ34552128-541C2D9F-56B7-4CCE-B5E0-346745FD017DQ35546878-ED04FE53-5A55-4868-A8BC-BCA052416B02Q37304964-0891C7EF-2E1A-4929-AAB2-C8D875013B43Q37311933-82263271-0C5A-405C-AA4B-FBE1C0BC1E7CQ38557486-1DDA6E46-D833-4475-AD96-09A003206284Q38815212-E44F2D9A-61E2-4832-8D28-632589BEE150Q39051110-9ECA34E5-2D77-4FD1-A697-51399C952FADQ47193084-35D88124-FF5B-47BF-8694-A6331B709BE2Q55160879-1BF73F1A-4A92-41C5-AE6B-07D74A2823D5
P2860
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetically engineered mouse m ...... the antitumor immune response.
@en
Genetically engineered mouse m ...... the antitumor immune response.
@nl
type
label
Genetically engineered mouse m ...... the antitumor immune response.
@en
Genetically engineered mouse m ...... the antitumor immune response.
@nl
prefLabel
Genetically engineered mouse m ...... the antitumor immune response.
@en
Genetically engineered mouse m ...... the antitumor immune response.
@nl
P2860
P1476
Genetically engineered mouse m ...... the antitumor immune response.
@en
P2093
Michel DuPage
Tyler Jacks
P2860
P304
P356
10.1016/J.COI.2013.02.005
P577
2013-03-04T00:00:00Z